Founded in Palo Alto, California, SyncThink, Inc. is a pioneering company in the field of eye-tracking technology, focusing on neurohealth assessments and performance optimization. Their core mission is to provide objective metrics for visual attention through innovative products like VR headsets. SyncThink's 60-second assessment evaluates ocular motor impairments and vestibular balance dysfunction, serving healthcare, biopharma, and sports sectors by supporting advanced patient care, accelerating CNS trials, and improving athlete safety.
SyncThink has garnered attention from top healthcare, pharmaceutical, and sports organizations for its groundbreaking technology. Notable affiliated individuals include leading neuroscientists and medical professionals who contribute to the company's research and development. Investors and partners include prominent venture capital firms and industry leaders in digital health. SyncThink's key achievements include widespread adoption in clinical settings and sports management, significantly impacting neurohealth diagnostics and patient outcomes.
